By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies has forged a partnership with GlaxoSmithKline Biologicals to develop a companion diagnostic test for GSK's candidate cancer immunotherapy, and gained regulatory approval in China for its Applied Biosystems 3500 Dx Genetic Analyzer, it announced separately after the close of the market on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.